T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRGI
1001
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $51.1M | ﹤0.01% |
4,662,906
+9,000
| +0.2% | +$113K |
|
1002
Relay Therapeutics
RLAY
$4.37B
| $51M | ﹤0.01% |
1,617,953
+444,471
| +38% | +$15M |
|
1003
CBRE Group
CBRE
$44B
| $51M | ﹤0.01% |
523,547
-8,600
| -2% | -$799K |
|
1004
Ryan Specialty Holdings
RYAN
$11B
| $50.8M | ﹤0.01% |
+1,499,833
| New | +$47.3M |
|
|
NXDR
1005
Nextdoor Holdings
NXDR
$998M
| $50.7M | ﹤0.01% |
+4,985,165
| New | +$51.3M |
|
1006
Vornado Realty Trust
VNO
$7.41B
| $50.6M | ﹤0.01% |
1,205,527
+946,382
| +365% | +$40.8M |
|
1007
Madison Square Garden
MSGS
$9.94B
| $50.6M | ﹤0.01% |
272,194
-278
| -0.1% | -$47.6K |
|
1008
Kinder Morgan
KMI
$71.4B
| $50.5M | ﹤0.01% |
3,018,612
-67,625
| -2% | -$1.15M |
|
1009
Jackson Financial
JXN
$9.1B
| $50.5M | ﹤0.01% |
+1,942,058
| New | +$52.8M |
|
|
RPTX
1010
DELISTED
Repare Therapeutics
RPTX
| $50.3M | ﹤0.01% |
1,915,973
+739,969
| +63% | +$23.9M |
|
|
REVHU
1011
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
| $49.8M | ﹤0.01% |
5,059,277
-2,419
| -0% | -$24K |
|
1012
Procept Biorobotics
PRCT
$1.26B
| $49.7M | ﹤0.01% |
+1,340,984
| New | +$51.5M |
|
1013
Williams Companies
WMB
$89.3B
| $49.5M | ﹤0.01% |
1,909,661
-33,421
| -2% | -$842K |
|
1014
Zymeworks
ZYME
$1.83B
| $49.3M | ﹤0.01% |
1,697,313
+647,666
| +62% | +$21.5M |
|
|
DICE
1015
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $49.2M | ﹤0.01% |
+1,502,249
| New | +$51.2M |
|
1016
J&J Snack Foods
JJSF
$1.7B
| $49.1M | ﹤0.01% |
321,163
-2,317
| -0.7% | -$377K |
|
1017
CareDx
CDNA
$2.45B
| $48.9M | ﹤0.01% |
771,409
-8,428
| -1% | -$642K |
|
1018
Hexcel
HXL
$7.74B
| $48.8M | ﹤0.01% |
821,865
+240,272
| +41% | +$13.9M |
|
|
CDR
1019
DELISTED
Cedar Realty Trust, Inc
CDR
| $48.7M | ﹤0.01% |
2,246,918
-193,692
| -8% | -$3.5M |
|
1020
REX American Resources
REX
$1.44B
| $48.7M | ﹤0.01% |
3,655,884
-9,054
| -0.2% | -$122K |
|
1021
BJs Wholesale Club
BJ
$11.9B
| $48.6M | ﹤0.01% |
884,663
+801,986
| +970% | +$42.8M |
|
1022
Realty Income
O
$59.6B
| $48.6M | ﹤0.01% |
772,798
-170,552
| -18% | -$11.5M |
|
1023
Rapid7
RPD
$929M
| $48.6M | ﹤0.01% |
429,603
+408,689
| +1,954% | +$46.3M |
|
1024
Phillips 66
PSX
$92.8B
| $48.3M | ﹤0.01% |
689,909
-12,497
| -2% | -$905K |
|
1025
Upstart Holdings
UPST
$3.01B
| $48.3M | ﹤0.01% |
+152,567
| New | +$30.1M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.